insulin and glp 1 agonist combination Schematic illustration of monoagonists, dual agonists triple How GLP-1 medications are transforming

Explore the mechanisms, clinical applications, and future opportunities of GLP-1 receptor agonists in drug development and disease management.

Tirzepatide), metabolic outcomes, and next-gen weight loss benefits

Some manufacturers offer single-dose vials, and you draw the medication up yourself using the supplied needle and syringe

What you need to know is covered in this article and infographic

Check with your health insurance or your employer health program to see if it is covered

Ahead of the Trump administrations planned expansion of Medicare coverage for GLP-1s to treat obesity through temporary models and the availability of Medicares negotiated price for certain GLP-1 products beginning in 2027, this analysis examines CMSs Medicare Part D claims data from 2019 to 2024 to document the increase in the number of beneficiaries being treated with GLP-1 drugs and the growth in Medicare spending and claims for these drugs.